🔎 Trials Near Me

Utama › Sindrom Kesukaran Pernafasan › South Carolina

Kajian klinikal Sindrom Kesukaran Pernafasan di South Carolina

7 kajian untuk Sindrom Kesukaran Pernafasan sedang mencari peserta di lokasi di South Carolina.

Bandar di South Carolina

Teks kajian rasmi (Bahasa Inggeris)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Greenville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

  • Medical University of South Carolina (MUSC), Charleston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701669

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

  • Medical University of South Carolina (MUSC), Charleston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701682

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

  • Medical University of South Carolina (MUSC), Charleston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701656

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

  • Medical University of South Carolina (MUSC), Charleston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06703073

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

  • Direct Biologics Investigational Site, Charleston
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 23 Feb 2026 · NCT05354141

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Medical University of South Carolina (MUSC), Charleston
  • McLeod Health, Florence
Mengambil pesertaKajian pemerhatian
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2025 · NCT06122077

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.